dc.contributor.author | Rauhamäki, Sanna | |
dc.date.accessioned | 2018-04-17T08:53:10Z | |
dc.date.available | 2018-04-17T08:53:10Z | |
dc.date.issued | 2018 | |
dc.identifier.isbn | 978-951-39-7397-1 | |
dc.identifier.other | oai:jykdok.linneanet.fi:1867870 | |
dc.identifier.uri | https://jyx.jyu.fi/handle/123456789/57631 | |
dc.description.abstract | The costs of the drug development process are moderated as computer-aided
drug design methods are able to expedite the steps required for lead
identification. In fact, computational tools are nowadays virtually indispensable
from target identification and validation to preclinical tests due to exponential
growth of available information regarding both potential targets and small
molecules. One such small molecule with growing number of variations is
coumarin. Coumarin scaffold and its various derivatives continue to interest
researchers for their vast application potential. Since naturally occurring
coumarins are known for example for their antioxidant and anti-inflammatory
properties, those molecules are used to guide research endeavors toward similar
molecules but with enhanced or newly directed activities. In this doctoral thesis,
coumarin derivatives are used to gain novel details regarding monoamine
oxidase and nuclear receptor modulation in context relevant for example in
neurological conditions and cancer. In order to achieve this, diverse collection of
coumarin derivatives is investigated in these targets and corresponding
antitargets using both computational and experimental methods. As a result,
novel coumarin derivatives with activity in nanomolar range are identified in
case of monoamine oxidase B and estrogen receptor ǂ and comparable activity is
reached for retinoid-acid-receptor-related orphan receptor DŽt with novel core. In
addition, the usability of coumarin derivatives as assay development tools is put
to test by designing selective ligands for glucuronidation. Consequently, the
metabolic fate of the coumarins is investigated as they are allocated to
metabolizing target using homology models, computational methods and
experimental techniques. Subsequently, two coumarin derivatives selective for
human uridine 5'-diphospho-glucuronosyltransferase 1A10 are identified. | |
dc.format.extent | 1 verkkoaineisto (91 sivua, 71 sivua useina numerointijaksoina, 22 numeroimatonta sivua) : kuvitettu | |
dc.language.iso | eng | |
dc.publisher | University of Jyväskylä | |
dc.relation.ispartofseries | Jyväskylä studies in biological and environmental science | |
dc.relation.haspart | <b>Artikkeli I:</b> Rauhamäki S., Postila P.A., Niinivehmas S., Kortet S., Schildt E., Pasanen
M., Manivannan E., Ahinko M., Koskimies P., Nyberg N., Huuskonen P.,
Multamäki E., Pasanen M., Juvonen R.O., Raunio H., Huuskonen J. &
Pentikäinen O.T. 2018. Structure-Activity Relationship Analysis of 3-
phenylcoumarin-Based Monoamine Oxidase B Inhibitors. Frontiers in
Chemistry 6: 41. </i><a href=" http://dx.doi.org/10.3389/fchem.2018.00041"target="_blank"> DOI: 10.3389/fchem.2018.00041.</a> | |
dc.relation.haspart | <b>Artikkeli II:</b> Niinivehmas S., Manivannan E., Rauhamäki S., Huuskonen J. &
Pentikäinen O.T. 2016. Identification of estrogen receptor α ligands with
virtual screening techniques. Journal of Molecular Graphics and Modeling 64:
30–39. </i><a href=" http://dx.doi.org/10.1016/j.jmgm.2015.12.006"target="_blank"> DOI: 10.1016/j.jmgm.2015.12.006.</a> | |
dc.relation.haspart | <b>Artikkeli III:</b> Niinivehmas S., Postila P.A., Rauhamäki S., Manivannan E., Kortet S.,
Ahinko M., Huuskonen P., Nyberg N., Koskimies P., Lätti S., Multamäki
E., Juvonen R.O., Raunio H., Pasanen M., Huuskonen J. & Pentikäinen O.T.
2018. Blocking oestradiol synthesis pathways with potent and selective
coumarin derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. </i><a href=" http://dx.doi.org/10.1080/14756366.2018.1452919"target="_blank"> DOI: 10.1080/14756366.2018.1452919.</a> | |
dc.relation.haspart | <b>Artikkeli IV:</b> Rauhamäki S., Postila P.A., Lätti S., Niinivehmas S., Multamäki E., Liedl K.
& Pentikäinen O.T. 2018. Discovery of Retinoic Acid-Related Orphan
Receptor DŽt Inverse Agonists via Docking and Negative Image-Based
Screening <i>Submitted manuscript. </i> | |
dc.relation.haspart | <b>Artikkeli V:</b> Juvonen R.O., Rauhamäki S., Kortet S., Niinivehmas S., Troberg J., Petsalo
A., Huuskonen J., Raunio H., Finel M. & Pentikäinen O.T. 2018. Molecular
Docking-Based Design and Development of a Highly Selective Probe
Substrate for UDP-glucuronosyltransferase 1A10. Molecular Pharmaceutics
15: 3: 923–933. </i><a href=" http://dx.doi.org/10.1021/acs.molpharmaceut.7b00871"target="_blank"> DOI: 10.1021/acs.molpharmaceut.7b008712.</a> | |
dc.relation.isversionof | Julkaistu myös painettuna. | |
dc.rights | In Copyright | |
dc.subject.other | tumareseptorit | |
dc.subject.other | 3-phenylcoumarin | |
dc.subject.other | 17β-hydroxysteroid dehydrogenase | |
dc.subject.other | cancer | |
dc.subject.other | computer-aided drug design | |
dc.subject.other | estrogen receptor | |
dc.subject.other | monoamine oxidase | |
dc.title | Small molecule modulators of amine oxidation, nuclear receptor signaling and glucuronidation : 3-phenylcoumarin as a scaffold of interest | |
dc.type | doctoral thesis | |
dc.identifier.urn | URN:ISBN:978-951-39-7397-1 | |
dc.type.dcmitype | Text | en |
dc.type.ontasot | Väitöskirja | fi |
dc.type.ontasot | Doctoral dissertation | en |
dc.contributor.tiedekunta | Faculty of Mathematics and Science | en |
dc.contributor.tiedekunta | Matemaattis-luonnontieteellinen tiedekunta | fi |
dc.contributor.yliopisto | University of Jyväskylä | en |
dc.contributor.yliopisto | Jyväskylän yliopisto | fi |
dc.contributor.oppiaine | Solu- ja molekyylibiologia | fi |
dc.type.coar | http://purl.org/coar/resource_type/c_db06 | |
dc.relation.issn | 1456-9701 | |
dc.relation.numberinseries | 345 | |
dc.rights.accesslevel | openAccess | |
dc.type.publication | doctoralThesis | |
dc.subject.yso | kumariinit | |
dc.subject.yso | molekyylilääketiede | |
dc.subject.yso | lääkesuunnittelu | |
dc.subject.yso | inhibiittorit | |
dc.subject.yso | entsyymit | |
dc.subject.yso | oksidoreduktaasit | |
dc.subject.yso | estrogeenit | |
dc.rights.url | https://rightsstatements.org/page/InC/1.0/ | |